|
|
|
 |
Guide to Cancer Therapeutic Regimens 2010
This review lists some of the common combination regimens and doses used in the cancers noted. It also lists selected single-agent regimens.
MAY, 2010
To request a free hard copy of this pocket guide, please click here |
|
|
|
 |
Oral Mucositis: Causative Regimens and Pathways for Treatment
Mucositis can be best described as a distinct and complex
pathobiologic entity resulting in mucosal barrier injuries
that is a consequence and frequent complication of chemotherapy
(CT) and radiation therapy (RT) in patients with cancer.
DECEMBER, 2008
To request a free hard copy of this pocket guide, please click here |
|
 |
Cancer Support 2009
Cancer is the second leading cause of death in the
United States (22.8% of all deaths), surpassed only
by heart disease. The lifetime probability of developing
cancer of any type is 1 in 2 for men and 1 in 3 for
women.
DECEMBER, 2008
|
|
 |
Therapeutic Strategies For Patients With Chronic Lymphocytic Leukemia
In the past 10 years, progress in the understanding of the biologic
basis of CLL, the introduction of novel prognostic factors to complement
the clinical staging systems, the use of monoclonal
antibodies, and the development of better measures of response
assessment have led to a revised approach to this most common of
the adult leukemias.
DECEMBER, 2007
|
|
|
|
|
|
 |
Treating The Patient With Metastatic Non–Smallcell Lung Cancer
Lung cancer is a major health problem worldwide. In the United States alone, it is estimated that 213,380 new cases of lung cancer will be diagnosed during the year 2007, second only to prostate cancer (in men) and breast cancer (in women).
SEPTEMBER, 2007
|
|
See more in the Pocket Guide Archives |
